Skip to main content
Journal of Feline Medicine and Surgery logoLink to Journal of Feline Medicine and Surgery
. 2013 May 10;15(12):1063–1069. doi: 10.1177/1098612X13488384

Prevalence and risk factor analysis of feline haemoplasma infection in New Zealand domestic cats using a real-time PCR assay

Kathryn S Jenkins 1,, Keren E Dittmer 1, Jonathan C Marshall 1, Séverine Tasker 2
PMCID: PMC10816462  PMID: 23666110

Abstract

Haemotropic mycoplasmas (haemoplasmas) are small epierythrocytic bacteria that have the potential to cause severe, life-threatening haemolytic anaemia. The aim of the current study was to evaluate feline haemoplasma prevalence using real-time polymerase chain reaction (PCR) from a convenience sample of New Zealand domestic cats, including blood film examination and a risk factor analysis. DNA was extracted from 200 blood samples submitted to a diagnostic laboratory for routine haematology over a 12-month period. Species-specific real-time PCR assays identified 62 cats that were positive for haemoplasma DNA, giving an overall prevalence of 31%. Twelve of the positive cats had dual infections. The prevalence of the three feline haemoplasmas was 25% for ‘Candidatus Mycoplasma haemominutum’, 7.5% for Mycoplasma haemofelis and 4.5% for ‘Candidatus Mycoplasma turicensis’ (CMt). All samples were positive for an internal control (feline 28S rDNA) by real-time PCR. Sensitivity and specificity of blood smear examination for haemoplasma infection in this study was 9.7% and 97.8%, respectively. Retroviral infection was tested using the Idexx Snap Feline Triple test on all samples. Twenty cats (10%) were feline immunodeficiency virus (FIV) positive and 11 cats (5.5%) were feline leukaemia virus (FeLV) positive. Statistical comparisons, using multivariate logistic regression, indicated that positive FIV status, male gender and non-pedigree breed were significantly (P <0.05) associated with haemoplasma infection, with odds ratios of 10.16, 5.04 and 3.03, respectively. The results of this study demonstrate the prevalence of the three main feline haemoplasma species in New Zealand for the first time, with prevalences correlating with previous overseas studies. This is the first report of CMt in New Zealand.

Introduction

Haemotropic mycoplasmas (haemoplasmas) are small, uncultivatable bacteria that parasitise erythrocytes of many domestic and wild animal species, including humans.1,2 From the 20 or so species of haemoplasmas currently reported, three species are well recognised to infect cats.3,4 Feline haemoplasma species vary in their pathogenicity 5 and can present with a wide spectrum of clinical disease, from severe, life-threatening haemolytic anaemia to non-symptomatic carrier states. 4 Mycoplasma haemofelis (Mhf) is widely regarded as the most pathogenic of the feline haemoplasmas, with both acute experimental and natural infection resulting in moderate-to-severe haemolytic anaemia.4,6 Candidatus Mycoplasma haemominutum (CMhm) and Candidatus Mycoplasma turicensis (CMt) are regarded to have lower pathogenic potential, with infection resulting in both smaller reductions in packed cell volume and fewer clinically significant signs of anaemia.7,8 Chronic carrier status with feline haemoplasma infections can also occur; such infections involving either CMhm or CMt can last months to years, even after appropriate antimicrobial therapy.3,9

The mode of transmission for haemoplasma infection has been the focus of numerous studies over the last decade, but remains poorly understood.1012 Aggressive social contact between cats, such as fighting and biting with the exchange of blood, would appear to be the strongest candidate for infection transmission. Experimental studies in this area have transmitted infection by subcutaneous inoculation of haemoplasma infected blood.13,14 Other modes have been investigated, including transmission through exchange of infected saliva via mutual grooming or sharing of food dishes 15 and transmission through haematophagous arthropod vectors, such as fleas or ticks;1618 however, direct evidence for these remains inconclusive.11,19,20

As haemoplasmas cannot be cultured in the laboratory, haemoplasma infection has been traditionally diagnosed by cytological examination of Romanowsky-stained blood smears.3,21,22 Cytological diagnosis is still used as a rapid bedside test in clinical practice today, but is unreliable as a sole method of haemoplasma diagnosis owing to poor diagnostic sensitivity and specificity. This is owing, in part, to cyclical fluctuation and variability in organism copy numbers, and is exacerbated by time-dependent detachment from erythrocytes after sampling.4,21,23,24 Polymerase chain reaction (PCR) was first used for the diagnosis of haemoplasma infection in 1998 and since then has become the diagnostic method of choice for both researchers and clinicians owing to its increased diagnostic sensitivity and specificity when compared with cytology.2527

The prevalence of haemoplasma infection in cats has not been previously investigated in New Zealand, despite the first cytological confirmation of Haemobartonella felis in this country occurring more than three decades ago. 14 The aim of the current study was to determine the prevalence of feline haemoplasma infection, including blood smear examination and evaluating risk factors for infection in New Zealand cats.

Materials and methods

Case material

A convenience sample of 200 ethylenediamine tetra-acetic acid (EDTA)-anticoagulated blood samples, submitted to New Zealand Veterinary Pathology Limited, Palmerston North, over a 12-month period was collected. The samples were from cats with a variety of disease conditions and were from localities throughout the country. The samples were chosen at random and were not specifically selected for anaemia. For each sample, data were recorded for potential risk factors, and blood smears generated on the day of collection as part of routine haematology. The smears were stained with Leishman’s stain (Fisher Scientific) and examined for evidence of haemoplasma infection using 1000× magnification. After initial storage for 5 days at 4°C, the samples were then held in long-term storage at −80°C, prior to DNA extraction.

DNA extraction

Frozen EDTA blood samples were thawed at room temperature and vortexed gently before removing 100 μl for DNA extraction using the DNeasy Blood and Tissue Kit (Qiagen) as per the manufacturer’s protocol. The DNA was eluted with 100 µl elution buffer, and DNA concentration quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Scientific). DNA was stored at −80°C prior to performing real-time PCR.

Primer and probe development

Sequences for feline 28S rDNA primers plus Mhf, CMhm and CMt species-specific primers and fluorescently-labelled sequence-specific probes have been reported previously.25,28 Primers were manufactured by Invitrogen New Zealand, and probes by Biosearch Technologies.

Real-time PCR

Real-time PCR assays were performed using a Rotor-Gene Q real-time PCR machine (Qiagen) and Rotor-Gene Probe PCR Master Mix. Each real-time PCR reaction consisted of 1 × Master Mix, 400 nM of each species-specific primer, 200 nM of each sequence- specific probe and 2.5 µl DNA, made up to a final volume of 12.5 µl with water. A separate reaction mix was set up for each species-specific primer/probe set. To confirm the presence of amplifiable DNA in the samples and the absence of PCR inhibitors, a feline 28S rDNA-specific primer and sequence specific probe was run in conjunction to the haemoplasma assays. A negative control (water) was included in each real-time PCR run to check for the presence of contaminants. DNA for each of the three haemoplasma species was used as a positive control for every real-time PCR run. Real-time PCR conditions consisted of an initial incubation step of 3 mins at 95°C, followed by 40 cycles of 95°C for 3 s (denaturation step) and 60°C for 10 s (combined annealing/extension step) during which fluorescence data were collected. Standard curves using 10-fold serial dilutions of DNA were generated for each haemoplasma species and feline 28S rDNA, to determine the efficiency (range 94–98%) and accuracy (correlation coefficient R2, range 0.94–0.99) of the real-time PCR reactions. The haemoplasma species specificity of the primer/probe sets were confirmed using real-time PCR and triple cross-checking using positive control DNA for each species against each primer/probe set and a negative control (water). Positive control samples and a selection of samples positive during real-time PCR testing were analysed on a 1.5% (w/v) UltraPure Agarose gel (Invitrogen) containing ethidium bromide and visualised under ultraviolet light on a transilluminator.

Sequencing reaction

Positive control samples and a selection of samples positive during real-time PCR testing were sequenced. Amplicons were purified using the QIAquick PCR Purification Kit (Qiagen) as per the manufacturer’s protocol. Using respective species-specific primers, the amplicons were subjected to automatic dye-terminator cycle sequencing with BigDye Terminator Version 3.1 Ready Reaction Cycle Sequencing kit on either the ABI3730 or ABI3130xl Genetic Analyser (Applied Biosystems).

Feline immunodeficiency virus/feline leukaemia virus testing

The Snap Feline Triple test (Idexx Laboratories) was used to assess retroviral infection status as per the manufacturer’s instructions.

Statistical analysis

Potential risk factors were evaluated using a multivariate logistic regression model and calculated using Minitab 15 statistical software (Minitab). Odds ratios (ORs) were calculated with a 95% confidence interval (CI). A P-value ≤ 0.05 was considered statistically significant. Potential risk factors evaluated in this study were feline immunodeficiency virus (FIV) status (negative vs positive), feline leukaemia virus (FeLV) status (negative vs positive), age (≤ 10 years vs > 10 years), breed (pedigree vs non-pedigree), presence of anaemia [haematocrit (HCT) ≤ 0.24 vs > 0.24], gender (male neutered vs female neutered) and seasonal variation (spring: September–November; summer: December–February; autumn: March–May; winter: June–August). Data were available for all 200 cats, apart from HCT, where one result was unavailable.

Results

Haemoplasma real-time PCR results

All reactions had efficiencies in excess of 94%. All positive and negative control reactions were positive and negative, respectively, and all 200 samples used in the study were positive for feline 28S rDNA, with CT values < 32. There was no cross-reactivity seen between the primer/probe sets and the non-target species, confirming the primer/probe sets were species-specific. When separated by agarose gel electrophoresis, the positive controls and selected positive samples each produced a single amplicon of expected size. A total of 200 cats was tested for haemoplasma infection by real-time PCR. Of these, 138 (69%) were negative and 62 (31%) cats were positive for haemoplasma DNA. A complete list of prevalence results can be found in Table 1. The amplicons obtained from real-time PCR of positive controls for Mhf, CMhm and CMt plus selected positive samples were sequenced. All sequences showed 100% identity to 16S ribosomal RNA for Mhf, CMhm and CMt, respectively.

Table 1.

Real-time polymerase chain reaction (PCR) results for feline haemoplasma infection in a sample of 200 New Zealand domestic cats

Real-time
PCR result
(n = 200)
Number of infected cats Percentage (%)
Haemoplasma positive 62 31
CMhm positive 50 25
Mhf positive 15 7.5
CMt positive 9 4.5
CMhm alone 38 19
Mhf alone 4 2
CMt alone 8 4
CMhm + Mhf 11 5.5
CMhm + CMt
CMhm + Mhf + CMt
1
0
0.5
0

CMhm = ‘Candidatus Mycoplasma haemominutum’; Mhf = Mycoplasma haemofelis; CMt = ‘Candidatus Mycoplasma turicensis’

Real-time PCR versus blood smear examination

Of the 200 samples randomly selected for real-time PCR, nine had haemoplasma infection diagnosed on blood smear examination by a veterinary diagnostic laboratory. Of these samples, 6/9 were subsequently positive on real-time PCR. Of the six PCR positive samples, two were Mhf positive and four had Mhf/CMhm dual infections. Based on the real-time PCR results, the sensitivity and specificity of blood smear examination for haemoplasma infection in this study was 9.7% and 97.8%, respectively. The negative predictive value was 70.7% and positive predictive value was 66.7%.

Risk associations

A multivariate logistic regression model was applied to data retrieved from laboratory submission forms and clinicopathological tests, and included gender, breed, FIV and FeLV infection status, age and anaemia status (Table 2). Male gender, non-pedigree breed and FIV infection were all found to be significant risk factors in this study (Table 2). Age, anaemia and FeLV infection did not represent significant risk factors when evaluated against being PCR positive or negative for feline haemoplasma infection (Table 2). Season also did not represent a significant risk factor (P = 0.765). Three subgroups were created to include all Mhf-infected cats, all CMhm-infected cats and all CMtc-infected cats, respectively, including singly and co-infected samples. These were also evaluated against the risk factors, with two further associations identified. A significant association between cats older than 10 years and CMhm infection was found (P = 0.001) with an OR of 3.13 (95% CI 1.52–6.25), and anaemia was significantly associated with Mhf infection (P = 0.018) with an OR of 0.21 (95% CI 0.06–0.70).

Table 2.

Sample characteristics and statistics of 200 domestic cats testing positive or negative for feline haemoplasma by real-time polymerase chain reaction (PCR), including gender, breed, feline leukaemia virus (FeLV) and feline immunodeficiency virus (FIV) infection status, age and anaemia status. Significant associations are shown in bold

Variable
(number of cats)
PCR negative (%) PCR positive (%) OR 95% CI P
Gender (n = 200)
 Male
 Female
62 (31) 76 (38) 48 (24) 14 (7) 5.04 2.32–10.97 <0.001
Breed (n = 200)
 Non-pedigree
 Pedigree
99 (49) 39 (19) 55 (28) 7 (4) 3.03 1.12–8.33 0.028
FeLV (n = 200)
 Positive
 Negative
6 (3) 132 (66) 5 (3) 57 (28) 1.75 0.68–4.48 0.247
FIV (n = 200)
 Positive
 Negative
4 (2) 134 (67) 16 (8) 46 (23) 10.16 2.88–35.89 <0.001
Age (n = 200)
 ≤10 years
 >10 years
73 (36) 65 (33) 23 (12) 39 (19) 1.93 0.94–3.96 0.07
Anaemia status (n = 199)
 Anaemic
 Non-anaemic
12 (6) 125 (63) 7 (3) 55 (28) 0.74 0.23–2.41 0.621

OR = odds ratio; CI = confidence interval

Discussion

This is the first study to report the presence and prevalence of haemoplasma infection with the three main feline haemoplasma species in a population of New Zealand cats, using real-time PCR. Haemoplasma infections were found to be highly prevalent, with haemoplasma DNA identified in 62/200 (31%) cats sampled. In addition, this is the first report of CMt infection in New Zealand. The samples in the present study were derived from those submitted to a central New Zealand veterinary diagnostic laboratory for haematology testing, and are likely to be comprised of unhealthy (sick) pet cats, but not directly suspected of haemoplasma infection. The total prevalence rate was similar to recent studies from Japan (26.4%), 29 the USA (28.1%), 30 Germany (27.8%), 31 Canada (38.3%) 32 and Australia (38.8%). 8 A higher percentage of infected cats has been reported from separate studies in Japan (58.3%) 33 and Ontario, Canada (60%). 17 This may be explained by the studies having much narrower sampling criteria, sampling only stray cats (Japan) and cats suspected to have haemoplasma infection (Ontario, Canada). Comparably lower total prevalence (range 3.9–20.9%) has been reported in studies over the last decade in which samples were collected from both healthy and sick cats.10,11,19,26,3439

Consistent with the majority of prevalence studies completed over the last decade (26/28 evaluated) CMhm was the most common haemoplasma species infecting cats in New Zealand. This would appear to reflect the efficient infection and replication with comparatively reduced virulence of this species. 29 Two notable studies did not follow this general trend. A report from Ontario, Canada, reported a strikingly high prevalence of Mhf infection (46.6%) amongst a small (n = 45) population of stray cats, 17 possibly reflecting the increased likelihood for transmission owing to aggressive behaviour and increased arthropod infestation in stray cats. A second study in South Africa described a remarkably high prevalence of CMt infection (26%) 8 with the study (similar to Fujihara et al 33 ) notably selecting specifically for cases suspicious of haemoplasma infection. Concurrent infections (with two or three feline haemoplasma species) have also been detected in the majority of prevalence studies that used quantitative real-time PCR, with overall co-infection rates ranging from 0.2 to 6.5% of cats.8,19,25,26,30,34,37,39,40 Co-infection with multiple haemoplasma species suggests there is no immunological cross-protection between the three feline haemoplasma species.8,41

Haemoplasma infection was detected by light microscopy examination of blood smears in 6/62 real-time PCR haemoplasma-positive cases in the present study, and all six were positive for Mhf infection. Some studies have suggested that Mhf is twice the size of the other two feline haemoplasma species,7,42 which may explain why it was more easily detected; however, a further nine Mhf and 47 other haemoplasma-infected blood samples were not identified by light microscopy. In previous prevalence studies, the sensitivity for cytological diagnosis has ranged from 0 to 37.5%.21,26,31,34 The low sensitivity is likely owing to the cyclical fluctuations of acute Mhf infection, and the smaller size and lower copy numbers of CMhm and CMt infections.5,27 Importantly, sensitivity can also be affected by haemoplasmas exhibiting a time-dependent detachment from erythrocytes, especially in blood stored in ETDA or heparin anticoagulant prior to a smear being made.23,43

Previous studies using quantitative DNA analysis found CMt had the lowest relative blood loads of the three species.19,25 The relative low loads of CMt, plus its smaller size, may help explain why this species has yet to be identified by light microscopy on blood smears, despite two recent experimental studies focusing on this species.9,42

Interpretation and comparison of data from individual haemoplasma prevalence studies over the last decade remains difficult. However, trends in regard to the strongest risk factors associated with haemoplasma infection have emerged. Those most significantly and repeatedly associated with infection include male gender, non-pedigree status and FIV infection.8,30,34,44 Other more loosely associated risk factors include older age, outdoor access, FeLV infection and a recent history of cat bite abscesses.31,3638 Consistent with the strongest trends, our study found that in haemoplasma PCR-positive cats, 80% were male, 89% were non-pedigree and these cats were 10 times more likely to be FIV-positive. The association with male sex and FIV seropositivity provides strong evidence for direct transmission of haemoplasma infection; 45 FIV infection is transmitted through bite wounds 46 and haemoplasma could be transmitted concurrently. However, it is also possible that FIV is associated with haemoplasma infection owing to the immunosuppressive effects that certain stages and strains of FIV infection induce.29,47

Consistent with previous epidemiological reports30,34,37 this study found that overall haemoplasma infection was not significantly associated with anaemia (P = 0.621). However, samples with Mhf infection (but not CMhm or CMt) were significantly associated with anaemia (P = 0.018) which supports Mhf being considered the more pathogenic species.19,48,49 Although not statistically significant, cats co-infected with both Mhf and CMhm were more likely to be older (average age: 12 years) and less likely to be anaemic (27% of samples) compared with cats with Mhf infection alone (average age: 3 years; 50% of samples anaemic). This could reflect a more prolonged or chronic clinical picture, as may be seen in a long-term carrier state commonly associated with CMhm infection.19,38,50 This is further supported in our study as older age (cats older than 10 years) was significantly associated with CMhm infection. The apparent diametric age distribution between Mhf and CMhm infection could be explained, at least in part, by the increased pathogenicity of Mhf compared with CMhm.41,51,52 Younger cats could be predisposed to infection with Mhf, having comparatively immature immune systems and also perhaps increased exposure due to aggressive social contact. Infection with CMhm is more likely to be found in older cats who have had an increased risk of exposure over time and produced a chronic asymptomatic carrier state. 30 A recent report 53 demonstrated a significantly higher acute phase response in Mhf-infected adult cats compared with CMhm, providing further strength to the pathogenic nature of Mhf.

The majority of domestic cats in New Zealand have outdoor access and could be exposed to disease transmission via vectors, such as fleas, especially in the summer and autumn months when flea populations are their highest. 54 New Zealand has limited potential for vector transmission via ticks as the only cattle tick present, Haemaphysalis longicornis, is an uncommon finding on companion animals outside the upper North Island. 55 Worldwide, vector-borne diseases have been shown to exhibit seasonal variation 37 and haemoplasma DNA has been amplified from fleas and ticks;1517 however, the current study did not find any association between haemoplasma infection and season. This may reflect either unusual seasonal characteristics that did not cause marked fluctuations in flea populations during this time period or, more likely, that blood-borne transmission via fleas is not the main route for haemoplasma transmission in New Zealand domestic cats.

The results of this convenience study should be interpreted with caution as it has selected for non-healthy cases. This may have resulted in a relatively higher prevalence rate compared with previous studies, which included a healthy sample population.11,25,37 As a result, the present study may not reflect the general New Zealand cat population. Further research in this area could include sampling healthy domestic cats from New Zealand to generate more accurate haemoplasma prevalence data regarding the general cat population.

Conclusions

This is the first study to report prevalence rates of feline haemoplasma infection using real-time PCR in a population of New Zealand cats, with haemoplasma infection found to be highly prevalent. This is also the first report of CMt in New Zealand. Statistical comparisons, using multivariate logistic regression, indicated that positive FIV status, male gender and non-pedigree breed were significantly (P <0.05) associated with haemoplasma infection. The results of this study demonstrate that New Zealand feline haemoplasma prevalence is similar to other overseas studies, with CMhm being the most common infection.

Acknowledgments

The authors would like to thank Eloise Jillings for reviewing the manuscript, Dr Laryssa Howe, Liz Burrows and Errol Kwan for laboratory assistance, and Raewynne Pearson and Margaret Anderson from New Zealand Veterinary Pathology Limited.

Footnotes

Funding: This work was supported by a grant from Massey University Research Fund category two research project.

The authors do not have any potential conflicts of interest to declare.

Accepted: 8 April 2013

References

  • 1. Steer JA, Tasker S, Barker EN, et al. A novel hemotropic mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia. Clin Infect Dis 2011; 53: e147–e51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Tasker S, Helps CR, Day MJ, et al. Phylogenetic analysis of hemoplasma species: an international study. J Clin Microbiol 2003; 41: 3877–3880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Sykes JE. Feline hemotropic mycoplasmas. Vet Clin North Am Small Anim Pract 2010; 40: 1157–1170. [DOI] [PubMed] [Google Scholar]
  • 4. Willi B, Boretti FS, Tasker S, et al. From Haemobartonella to hemoplasma: molecular methods provide new insights. Vet Microbiol 2007; 125: 197–209. [DOI] [PubMed] [Google Scholar]
  • 5. Tasker S. Current concepts in feline haemobartonellosis. In Pract. 2006; 28: 136–141. [Google Scholar]
  • 6. Tasker S, Helps CR, Day MJ, et al. Use of real-time PCR to detect and quantify Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ DNA. J Clin Microbiol 2003; 41: 439–441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Foley JE, Pedersen NC. ’Candidatus Mycoplasma haemominutum’, a low virulence epierythrocytic parasite of cats. Int J Syst Evol Microbiol 2001; 51: 815–817. [DOI] [PubMed] [Google Scholar]
  • 8. Willi B, Tasker S, Boretti FS, et al. Phylogenetic analysis of ‘Candidatus Mycoplasma turicensis’ isolates from pet cats in the United Kingdom, Australia, and South Africa, with analysis of risk factors for infection. J Clin Microbiol 2006; 44: 4430–4435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Novacco M, Boretti FS, Wolf-Jäckel GA, et al. Chronic ‘Candidatus mycoplasma turicensis’ infection. Vet Res 2011; 42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Bennett AD, Gunn-Moore DA, Brewer M, Lappin MR. Prevalence of Bartonella species, haemoplasmas and Toxoplasma gondii in cats in Scotland. J Feline Med Surg 2011; 13: 553–557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Barrs VR, Beatty JA, Wilson BJ, et al. Prevalence of Bartonella species, Rickettsia felis, haemoplasmas and the Ehrlichia group in the blood of cats and fleas in eastern Australia. Aust Vet J 2010; 88: 160–165. [DOI] [PubMed] [Google Scholar]
  • 12. Willi B, Meli ML, Lüthy R, et al. Development and application of a universal hemoplasma screening assay based on the SYBR green PCR principle. J Clin Microbiol 2009; 47: 4049–4054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Museux K, Boretti FS, Willi B, et al. In vivo transmission studies of ’Candidatus Mycoplasma turicensis’ in the domestic cat. Vet Res 2009; 40: 45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Anderson DC, Charleston WA. Haemobartonella felis. N Z Vet J 1967; 15: 47. [DOI] [PubMed] [Google Scholar]
  • 15. Willi B, Boretti FS, Meli ML, et al. Real-time PCR investigation of potential vectors, reservoirs, and shedding patterns of feline hemotropic mycoplasmas. Appl Environ Microbiol 2007; 73: 3798–3802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Lappin MR, Griffin B, Brunt J, et al. Prevalence of Bartonella species, haemoplasma species, Ehrlichia species, Anaplasma phagocytophilum, and Neorickettsia risticii DNA in the blood of cats and their fleas in the United States. J Feline Med Surg 2006; 8: 85–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Kamrani A, Parreira VR, Greenwood J, Prescott JF. The prevalence of Bartonella, hemoplasma, and Rickettsia felis infections in domestic cats and in cat fleas in Ontario. Can J Vet Res 2008; 72: 411–419. [PMC free article] [PubMed] [Google Scholar]
  • 18. Taroura S, Shimada Y, Sakata Y, et al. Detection of DNA of ’Candidatus Mycoplasma haemominutum’ and Spiroplasma sp in unfed ticks collected from vegetation in Japan. J Vet Med Sci 2005; 67: 1277–1279. [DOI] [PubMed] [Google Scholar]
  • 19. Willi B, Boretti FS, Baumgartner C, et al. Prevalence, risk factor analysis, and follow-up of infections caused by three feline hemoplasma species in cats in Switzerland. J Clin Microbiol 2006; 44: 961–969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Woods JE, Wisnewki N, Lappin MR. Attempted transmission of Candidatus Mycoplasma haemominutum and Mycoplasma haemofelis by feeding cats infected Ctenocephalides felis. Am J Vet Res 2006; 67: 494–497. [DOI] [PubMed] [Google Scholar]
  • 21. Tasker S. Haemotropic mycoplasmas. What’s their real significance in cats? J Feline Med Surg 2010; 12: 369–381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Messick JB. Hemotrophic mycoplasmas (hemoplasmas): a review and new insights into pathogenic potential. Vet Clin Pathol 2004; 33: 2–13. [DOI] [PubMed] [Google Scholar]
  • 23. Allison RW, Fielder SE, Meinkoth JH. What is your diagnosis? Blood film from an icteric cat. Vet Clin Pathol 2010; 39: 125–126. [DOI] [PubMed] [Google Scholar]
  • 24. Meli ML, Willi B, Dreher UM, et al. Identification, molecular characterization, and occurrence of two bovine hemoplasma species in Swiss cattle and development of real-time TaqMan quantitative PCR assays for diagnosis of bovine hemoplasma infections. J Clin Microbiol 2010; 48: 3563–3568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Peters IR, Helps CR, Willi B, et al. The prevalence of three species of feline haemoplasmas in samples submitted to a diagnostics service as determined by three novel real-time duplex PCR assays. Vet Microbiol 2008; 126: 142–150. [DOI] [PubMed] [Google Scholar]
  • 26. Jensen WA, Lappin MR, Kamkar S, Reagan WJ. Use of a polymerase chain reaction assay to detect and differentiate two strains of Haemobartonella felis in naturally infected cats. Am J Vet Res 2001; 62: 604–608. [DOI] [PubMed] [Google Scholar]
  • 27. Messick JB, Berent LM, Cooper SK. Development and evaluation of a PCR-based assay for detection of Haemobartonella felis in cats and differentiation of H felis from Related bacteria by restriction fragment length polymorphism analysis. J Clin Microbiol 1998; 36: 462–466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Helps CR, Lait P, Damhuis A, et al. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet Rec 2005; 156: 669–673. [DOI] [PubMed] [Google Scholar]
  • 29. Tanahara M, Miyamoto S, Nishio T, et al. An epidemiological survey of feline hemoplasma infection in Japan. J Vet Med Sci 2010; 72: 1575–1581. [DOI] [PubMed] [Google Scholar]
  • 30. Sykes JE, Terry JC, Lindsay LL, Owens SD. Prevalences of various hemoplasma species among cats in the United States with possible hemoplasmosis. J Am Vet Med Assoc 2008; 232: 372–379. [DOI] [PubMed] [Google Scholar]
  • 31. Bauer N, Balzer HJ, Thüre S, Moritz A. Prevalence of feline haemotropic mycoplasmas in convenience samples of cats in Germany. J Feline Med Surg 2008; 10: 252–258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Kewish KE, Appleyard GD, Myers SL, et al. Mycoplasma haemofelis and Mycoplasma haemominutum detection by polymerase chain reaction in cats from Saskatchewan and Alberta. Can Vet J 2004; 45: 749–752. [PMC free article] [PubMed] [Google Scholar]
  • 33. Fujihara M, Watanabe M, Yamada T, Harasawa R. Occurrence of ’Candidatus Mycoplasma turicensis’ infection in domestic cats in Japan. J Vet Med Sci 2007; 69: 1061–1063. [DOI] [PubMed] [Google Scholar]
  • 34. Tasker S, Binns SH, Day MJ, et al. Use of a PCR assay to assess the prevalence and risk factors for Mycoplasma haemofelis and ’Candidatus Mycoplasma haemominutum’ in cats in the United Kingdom. Vet Rec 2003; 152: 193–198. [DOI] [PubMed] [Google Scholar]
  • 35. Roura X, Peters IR, Altet L, et al. Prevalence of hemotropic mycoplasmas in healthy and unhealthy cats and dogs in Spain. J Vet Diagn Invest 2010; 22: 270–274. [DOI] [PubMed] [Google Scholar]
  • 36. Maher IE, Tasker S, Polizopoulou Z, et al. Polymerase chain reaction survey of feline haemoplasma infections in Greece. J Feline Med Surg 2010; 12: 601–605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Gentilini F, Novacco M, Turba ME, et al. Use of combined conventional and real-time PCR to determine the epidemiology of feline haemoplasma infections in northern Italy. J Feline Med Surg 2009; 11: 277–285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Sykes JE, Drazenovich NL, Ball LM, Leutenegger CM. Use of conventional and real-time polymerase chain reaction to determine the epidemiology of hemoplasma infections in anemic and nonanemic cats. J Vet Intern Med 2007; 21: 685–693. [DOI] [PubMed] [Google Scholar]
  • 39. Luria BJ, Levy JK, Lappin MR, et al. Prevalence of infectious diseases in feral cats in Northern Florida. J Feline Med Surg 2004; 6: 287–296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Lobetti RG, Tasker S. Diagnosis of feline haemoplasma infection using a real-time PCR assay. J S Afr Vet Assoc 2004; 75: 94–99. [DOI] [PubMed] [Google Scholar]
  • 41. Westfall DS, Jensen WA, Reagan WJ, et al. Inoculation of two genotypes of Hemobartonella felis (California and Ohio variants) to induce infection in cats and the response to treatment with azithromycin. Am J Vet Res 2001; 62: 687–691. [DOI] [PubMed] [Google Scholar]
  • 42. Willi B, Museux K, Novacco M, et al. First morphological characterization of ’Candidatus Mycoplasma turicensis’ using electron microscopy. Vet Microbiol 2011; 149: 367–373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Meli ML, Kaufmann C, Zanolari P, et al. Development and application of a real-time TaqMan qPCR assay for detection and quantification of ’Candidatus Mycoplasma haemolamae’ in South American camelids. Vet Microbiol 2010; 146: 290–294. [DOI] [PubMed] [Google Scholar]
  • 44. Laberke S, Just F, Pfister K, Hartmann K. Prevalence of feline haemoplasma infection in cats in Southern Bavaria, Germany, and infection risk factor analysis. Berl Munch Tierarztl Wochenschr 2010; 123: 42–48. [PubMed] [Google Scholar]
  • 45. Natoli E, Say L, Cafazzo S, et al. Bold attitude makes male urban feral domestic cats more vulnerable to feline immunodeficiency virus. Neurosci Biobehav Rev 2005; 29: 151–157. [DOI] [PubMed] [Google Scholar]
  • 46. Hayward JJ, Rodrigo AG. Molecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus). Vet Immunol Immunopathol 2010; 134: 68–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Tasker S, Caney SMA, Day MJ, et al. Effect of chronic FIV infection, and efficacy of marbofloxacin treatment, on Mycoplasma haemofelis infection. Vet Microbiol 2006; 117: 169–79. [DOI] [PubMed] [Google Scholar]
  • 48. Tasker S, Peters IR, Day MJ, et al. Distribution of Mycoplasma haemofelis in blood and tissues following experimental infection. Microb Pathogen 2009; 47: 334–340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Sykes JE. Feline hemotropic mycoplasmosis (feline hemobartonellosis). Vet Clin North Am Small Anim Pract 2003; 33: 773–789. [DOI] [PubMed] [Google Scholar]
  • 50. Tasker S, Braddock JA, Baral R, et al. Diagnosis of feline haemoplasma infection in Australian cats using a real-time PCR assay. J Feline Med Surg 2004; 6: 345–354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Foley JE, Harrus S, Poland A, et al. Molecular, clinical, and pathologic comparison of two distinct strains of Haemobartonella felis in domestic cats. Am J Vet Res 1998; 59: 1581–1588. [PubMed] [Google Scholar]
  • 52. Tasker S, Peters IR, Papasouliotis K, et al. Description of outcomes of experimental infection with feline haemoplasmas: copy numbers, haematology, Coombs’ testing and blood glucose concentrations. Vet Microbiol 2009; 139: 323–332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Korman RM, Ceron JJ, Knowles TG, et al. Acute phase response to Mycoplasma haemofelis and ’Candidatus Mycoplasma haemominutum’ infection in FIV-infected and non-FIV-infected cats. Vet J 2012; 193: 433–438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Kelly PJ. A review of bacterial pathogens in Ctenocephalides felis in New Zealand. N Z Vet J 2004; 52: 352–357. [DOI] [PubMed] [Google Scholar]
  • 55. Heath ACG. Ectoparasites of livestock and companion animals in New Zealand. N Z Vet J 2002; 50: 48. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Feline Medicine and Surgery are provided here courtesy of SAGE Publications

RESOURCES